Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Targeted Stellate Ganglion Morphine Infiltration on Reperfusion Injury in STEMI Patients After Primary PCI: A Multi-Center Randomized Controlled Trial

NCT07023679 is registered in ClinicalTrials.gov with The Second Hospital of Anhui Medical University as lead sponsor.

NCT NCT07023679
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07023679 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Targeted Stellate Ganglion Morphine Infiltration on Reperfusion Injury in STEMI Patients After Primary PCI: A Multi-Center Randomized Controlled Trial
Lead sponsor
The Second Hospital of Anhui Medical University
Phase
Not applicable
Overall status
Recruiting
Start date
June 24, 2025
Completion date
June 20, 2029
Enrollment
2,588 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute myocardial infarction (ami)